Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Stem Cell Reports
|
May 20, 2022
Esrrb is a cell-cycle-dependent associated factor balancing pluripotency and XEN differentiation
Sapir Herchcovici Levy, Sharon Feldman Cohen, Lee Arnon, et al.
Voprosy Onkologii
|
January 1, 1992
[Neoadjuvant chemotherapy in combined treatment of breast cancer]
V F Semiglazov, E E Topuzov, Ia L Bavli, et al.
Pharmaceutics
|
December 28, 2021
Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria
Ahuva Cern, Yaelle Bavli, Atara Hod, et al.
ACS Nano
|
July 27, 2019
Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions
Gergely Tibor Kozma, Tamás Mészáros, Ildikó Vashegyi, et al.
Medicine
|
March 1, 1979
Response to saralasin and angiotensin's role in essential and renal hypertension
N K Hollenberg, G H Williams, D F Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer
V F Semiglazov, E E Topuzov, J L Bavli, et al.
Iscience
|
January 24, 2022
Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity
Etty Kruzel-Davila, Ira Bavli-Kertselli, Ayala Ofir, et al.
Cancer
|
May 15, 1986
Clinical trials on adjuvant chemotherapy for breast cancer
V F Semiglazov, J L Bavli, V M Moiseyenko, et al.
European Journal of Epidemiology
|
July 1, 1992
The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad)
V F Semiglazov, V M Moiseyenko, J L Bavli, et al.
The New England Journal of Medicine
|
July 17, 2025
Monoclonal Anti-Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss
Natalie R Bavli, Adam J Kanack, Yoshito Nishimura, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Stem Cell Reports
|
May 20, 2022
Esrrb is a cell-cycle-dependent associated factor balancing pluripotency and XEN differentiation
Sapir Herchcovici Levy, Sharon Feldman Cohen, Lee Arnon, et al.
Voprosy Onkologii
|
January 1, 1992
[Neoadjuvant chemotherapy in combined treatment of breast cancer]
V F Semiglazov, E E Topuzov, Ia L Bavli, et al.
Pharmaceutics
|
December 28, 2021
Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria
Ahuva Cern, Yaelle Bavli, Atara Hod, et al.
ACS Nano
|
July 27, 2019
Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions
Gergely Tibor Kozma, Tamás Mészáros, Ildikó Vashegyi, et al.
Medicine
|
March 1, 1979
Response to saralasin and angiotensin's role in essential and renal hypertension
N K Hollenberg, G H Williams, D F Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer
V F Semiglazov, E E Topuzov, J L Bavli, et al.
Iscience
|
January 24, 2022
Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity
Etty Kruzel-Davila, Ira Bavli-Kertselli, Ayala Ofir, et al.
Cancer
|
May 15, 1986
Clinical trials on adjuvant chemotherapy for breast cancer
V F Semiglazov, J L Bavli, V M Moiseyenko, et al.
European Journal of Epidemiology
|
July 1, 1992
The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad)
V F Semiglazov, V M Moiseyenko, J L Bavli, et al.
The New England Journal of Medicine
|
July 17, 2025
Monoclonal Anti-Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss
Natalie R Bavli, Adam J Kanack, Yoshito Nishimura, et al.
Page
of 10